ES2192586T3 - Formulaciones y procedimientos para reducir la irritacion de la piel. - Google Patents

Formulaciones y procedimientos para reducir la irritacion de la piel.

Info

Publication number
ES2192586T3
ES2192586T3 ES95943956T ES95943956T ES2192586T3 ES 2192586 T3 ES2192586 T3 ES 2192586T3 ES 95943956 T ES95943956 T ES 95943956T ES 95943956 T ES95943956 T ES 95943956T ES 2192586 T3 ES2192586 T3 ES 2192586T3
Authority
ES
Spain
Prior art keywords
formulations
procedures
skin irritation
reduce skin
irritant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95943956T
Other languages
English (en)
Inventor
Gary Scott Hahn
David Orel Thueson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cosmederm Technologies Inc
Original Assignee
Cosmederm Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosmederm Technologies Inc filed Critical Cosmederm Technologies Inc
Application granted granted Critical
Publication of ES2192586T3 publication Critical patent/ES2192586T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q9/00—Preparations for removing hair or for aiding hair removal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE PROPONEN COMPOSICIONES Y METODOS PARA INHIBIR LA IRRITACION DE LA PIEL ATRIBUIBLE A IRRITANTES QUIMICOS O CONDICIONES MEDIOAMBIENTALES, MEDIANTE LA APLICACION DE UNA CANTIDAD DE ANTIIRRITANTE DE UN CATION DE ALUMINIO TRIVALENTE SOLUBLE EN AGUA O UN CATION DE ESTAÑO DIVALENTE.
ES95943956T 1994-12-21 1995-12-21 Formulaciones y procedimientos para reducir la irritacion de la piel. Expired - Lifetime ES2192586T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36205894A 1994-12-21 1994-12-21

Publications (1)

Publication Number Publication Date
ES2192586T3 true ES2192586T3 (es) 2003-10-16

Family

ID=23424524

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95943956T Expired - Lifetime ES2192586T3 (es) 1994-12-21 1995-12-21 Formulaciones y procedimientos para reducir la irritacion de la piel.

Country Status (13)

Country Link
US (1) US6455076B1 (es)
EP (1) EP0801554B1 (es)
JP (2) JPH11502504A (es)
AT (1) ATE237298T1 (es)
AU (1) AU4528596A (es)
BR (1) BR9510478A (es)
CA (1) CA2208078C (es)
DE (1) DE69530418T2 (es)
DK (1) DK0801554T3 (es)
ES (1) ES2192586T3 (es)
MX (1) MX9704776A (es)
PT (1) PT801554E (es)
WO (1) WO1996019183A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7261910B2 (en) * 2003-02-14 2007-08-28 Ordonez Jacome Neptali Rene Cr Method of obtaining and treating compounds from ozonized unsaturated vegetable oils for pharmaceutical compositions for medical and veterinary use

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719474B1 (fr) 1994-05-05 1996-05-31 Oreal Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.
US6203803B1 (en) 1994-12-14 2001-03-20 Societe L'oreal S.A. Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained
US7404967B2 (en) * 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
US6139850A (en) * 1994-12-21 2000-10-31 Cosmederm Technologies Formulations and methods for reducing skin irritation
US5716625A (en) * 1994-12-21 1998-02-10 Cosmederm Technologies Formulations and methods for reducing skin irritation
MX9710479A (es) 1995-09-07 1998-03-31 Oreal Extracto de iridaceas y composiciones que la contienen.
FR2740335B1 (fr) 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p
FR2740342B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de manganese, de lithium, d'etain, de zinc ou d'yttrium, de cobalt, de baryum, de strontium dans des compositions pharmaceutiques
FR2740341B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau
US5958436A (en) * 1995-12-21 1999-09-28 Cosmederm Technologies Formulations and methods for reducing skin irritation
US5853709A (en) * 1996-12-12 1998-12-29 Johnson Products Co., Inc. Shaving composition and method for preventing pseudofolliculitis barbae
US6168798B1 (en) * 1997-02-03 2001-01-02 Bristol-Myers Squibb Company Non-irritating composition for treating acne and other skin conditions
CH692238A5 (de) * 1997-12-16 2002-04-15 Spirig Pharma Ag Hautschutzzubereitung.
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US20050100563A1 (en) * 2001-01-26 2005-05-12 Hexamer Don L. Antifungal compositions and methods of treatment therewith
US6676953B2 (en) 2001-01-26 2004-01-13 Don L. Hexamer Antifungal composition and method for human nails
AU2002314847A1 (en) 2001-05-31 2002-12-09 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
EP1450824A4 (en) * 2001-11-02 2005-09-28 Elan Corp Plc PHARMACEUTICAL COMPOSITION
EP1551402A4 (en) * 2002-09-23 2009-05-27 Verion Inc PHARMACEUTICAL COMPOSITIONS NOT INDUCING ABUSE
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
IL156670A0 (en) * 2003-06-26 2004-01-04 Zvi Zolotariov Aloe suppositories
US20050025817A1 (en) * 2003-07-03 2005-02-03 Bhatia Kuljit S. Delivery system for topical medications
US7776355B2 (en) * 2003-07-03 2010-08-17 Medics Pharmaceutical Corporation Delivery system for topical medications
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US7479289B2 (en) * 2004-07-02 2009-01-20 Medicis Pharmaceutical Corporation Stable cleanser compositions containing sulfur
US7655682B2 (en) * 2004-07-02 2010-02-02 Medicis Pharmaceutical Corporation Triple anti-irritant composition
WO2007046097A2 (en) * 2005-10-21 2007-04-26 Medidermis Ltd. Topical compositions for the treatment of depilation-induced skin irritation or prevention thereof
DE102006003925A1 (de) * 2006-01-26 2007-08-02 Henkel Kgaa Aufhell- und/oder Färbemittel mit reduziertem Irritationspotential
US20070281002A1 (en) * 2006-05-31 2007-12-06 Sara Morales Low irritation antimicrobial cleaning substrate
US7723387B2 (en) * 2006-06-28 2010-05-25 Polymer Surfaces Group, Llc Self-neutralizing acid peel for dermatologic use
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US7687084B2 (en) * 2007-08-06 2010-03-30 Tien Linsheng W Cool-pet system
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2009090558A2 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
ITMI20080444A1 (it) 2008-03-17 2009-09-18 Giuliani Spa Agenti per contrastare e ridurre l'azione irritante dei tensioattivi in composizioni da applicare sulla pelle per la cura o la detersione del viso e del corpo
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CN102686205A (zh) 2009-10-02 2012-09-19 弗艾米克斯有限公司 局部四环素组合物
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
EP2540303A1 (en) 2011-06-28 2013-01-02 Johnson & Johnson Consumer Companies Inc. Divalent cation containing compositions and methods for treating and/or preventing enzymatic irritation
US20130004590A1 (en) 2011-06-28 2013-01-03 Lin Connie B Zinc oxide/acid containing compositions and methods for treating and/or preventing enzymatic irritation
US20130004580A1 (en) 2011-06-28 2013-01-03 Lin Connie B Divalent cation/talc containing compositions and methods for treating and/or preventing enzymatic irritation
BR112014005492A2 (pt) * 2011-09-09 2017-06-13 Gaba Int Holding Ag composições estáveis e métodos para preparar as mesmas
US8741360B2 (en) 2011-10-26 2014-06-03 Javad Ghoreishi Topical therapeutic composition and palliative treatment method
US8475852B2 (en) 2011-10-26 2013-07-02 Javad Ghoreishi Topical therapeautic composition and palliative treatment method
DE102012224157A1 (de) * 2012-12-21 2014-06-26 Henkel Ag & Co. Kgaa Textil schonende Antitranspirant-Sprays mit Hydroxycarbonsäuren
US9861645B2 (en) 2012-12-28 2018-01-09 Rak Holdings Llc Anti-itch scalp treatment compositions and combinations
WO2017117155A1 (en) * 2015-12-30 2017-07-06 Colgate-Palmolive Company Personal care compositions
BR112018071831B1 (pt) 2016-05-10 2021-08-31 Colgate-Palmolive Company Composição de higiene pessoal, método não terapêutico de redução do suor e/ou odor corporal, método não terapêutico de eliminação de bactérias, método de formação de uma composição de higiene pessoal de irritação reduzida e uso não terapêutico de agente ativo antitranspirante
DE102016209980A1 (de) * 2016-06-07 2017-12-07 Henkel Ag & Co. Kgaa "Nachbehandlungsmittel für die reduktive Entfärbung von gefärbten keratinischen Fasern"
MX2017011630A (es) 2016-09-08 2018-09-25 Foamix Pharmaceuticals Ltd Composiciones y metodos para tratar rosacea y acne.
JPWO2019189380A1 (ja) * 2018-03-29 2020-12-03 株式会社マンダム Ｔｒｐチャネル活性抑制剤
EP4014962A1 (de) * 2020-12-16 2022-06-22 Novigo GmbH & Co. KG Zusammensetzung mit osmotisch wirksamer substanz und verwendung der zusammensetzung

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE35991B1 (en) 1971-01-22 1976-07-21 Comprehensive Pharmaceuticals Improvements in or relating to the treatment of diseases of the skin and mucosa
US4053630A (en) 1976-07-07 1977-10-11 Yu Ruey J Treatment of body odor and disturbed keratinization
US4331653A (en) * 1977-08-18 1982-05-25 Robert Brown Composition for a topical cream for curtailing bleeding and treating skin disorders
US4283386A (en) 1978-10-10 1981-08-11 Scott Eugene J Van Method for hair care
AU548560B2 (en) * 1980-05-20 1985-12-19 Vipont Laboratories Inc. Benzophenanthridine alkaloids as antimicrobial agents
US4367224A (en) * 1981-05-13 1983-01-04 Scott Eugene J Van Stable dithranol compositions in anhydrous vehicles
DE3584837D1 (de) 1985-10-08 1992-01-16 Psori Med Ag Salzmischung zur behandlung der schuppenflechte (psoriasis) und anderer hautkrankheiten.
US4879116A (en) * 1988-06-13 1989-11-07 Charles Fox Skin protein complexing composition for the potentiation of the substantivity of aluminum acetate through the use of a cationic emulsifier as an aid in skin healing
US4840798A (en) 1988-07-27 1989-06-20 Theon, Inc. Astringent gel composition and method for use
DE3929411A1 (de) * 1988-09-22 1990-03-29 Siegfried Natterer Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung
US5102670A (en) * 1990-09-14 1992-04-07 Abraham Nader G Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels
GB9110652D0 (en) 1991-05-15 1991-07-03 Stiefel Laboratories Composition and method of treating depigmentation disorders
US5217710A (en) * 1992-03-05 1993-06-08 Chesebrough-Pond's Usa Co. Stabilized peroxide gels containing fluoride
WO1993025211A1 (en) 1992-06-16 1993-12-23 Embro Research Corporation Treatment for cutaneous pain, itching and inflammation with topical stannous fluoride
US5411731A (en) * 1992-07-21 1995-05-02 Kao Corporation Bath additive composition comprising aluminum salt and carbonate or bicarbonate which yields a bath water of pH 8 to 9
US5674505A (en) * 1992-12-10 1997-10-07 Hemogen, Inc. Method for treating non-ocular epithelial disorders via increasing heme oxygenase levels and/or decreasing levels of arachidonic acid derivatives
WO1995026198A1 (en) 1994-03-28 1995-10-05 Skin Biology, Inc. Metal complexes of aloe extracts for skin and hair

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7261910B2 (en) * 2003-02-14 2007-08-28 Ordonez Jacome Neptali Rene Cr Method of obtaining and treating compounds from ozonized unsaturated vegetable oils for pharmaceutical compositions for medical and veterinary use

Also Published As

Publication number Publication date
DK0801554T3 (da) 2003-08-04
PT801554E (pt) 2003-08-29
US6455076B1 (en) 2002-09-24
BR9510478A (pt) 1998-12-15
EP0801554B1 (en) 2003-04-16
AU4528596A (en) 1996-07-10
CA2208078A1 (en) 1996-06-27
JPH11502504A (ja) 1999-03-02
MX9704776A (es) 1998-02-28
ATE237298T1 (de) 2003-05-15
EP0801554A1 (en) 1997-10-22
DE69530418T2 (de) 2004-03-11
WO1996019183A1 (en) 1996-06-27
CA2208078C (en) 2009-06-23
EP0801554A4 (en) 2000-03-29
JP2005314437A (ja) 2005-11-10
DE69530418D1 (de) 2003-05-22

Similar Documents

Publication Publication Date Title
ES2192586T3 (es) Formulaciones y procedimientos para reducir la irritacion de la piel.
ES2181812T3 (es) Formulaciones y procedimientos para reducir la irritacion de la piel.
MX9704778A (es) Formulaciones para reducir irritaciones de la piel y uso de las mismas.
BR9915822B1 (pt) derivados de pirazolopirimidinona e sua composição farmacêutica para o tratamento de impotência
BR9610849A (pt) Composição de limpeza pessoal e processo para a inibiçao da perda de umidade pela pele e proteção da pele
NZ295211A (en) Topical aqueous gel containing a water-soluble cellulose derivative, propylene glycol & drug(s) for haemorrhoids
BR9510488A (pt) Formulações e métodos para redução da irritação da pele
ES2192832T3 (es) Uso de compuestos macrolidos para tratar glaucoma.
DK165903C (da) Farmaceutisk praeparat mod acne
ATE53489T1 (de) Zusammensetzung zur behandlung von hauterkrankungen und ihre verwendung.
DE69927260D1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
BR9103985A (pt) Compostos,processos para a sua preparacao,composicao contra protozoarios parasitarios,emprego,processos para combater protozoarios e para a preparacao de composicoes
BR0009194A (pt) Composição do resorcinol
SE7506559L (sv) Bindor
ES2196645T3 (es) Composiciones transparentes para el cuidado de la piel.
MX9301627A (es) Agente para utilizarse como un antiirritante y composicion que lo contiene.
ES2058097T3 (es) Agente antibacterial para su uso en mamiferos y que comprende derivados de cefalosporina como ingrediente activo.
ES2052160T3 (es) Cosmeticos.
PT998929E (pt) Composicoes farmaceuticas topicas para cicatrizacao de feridas contendo borneol e subgalhato de bismuto
KR960037810A (ko) 입상 소금을 함유하는 인체용 세제 조성물
ES529696A0 (es) Procedimiento de preparacion de tetrahidro-tiacin-2,4-dion para el tratamiento de la piel.
MX9704732A (es) Formulaciones para reducir irritacion de la piel y su uso.